Medication info

Periplus 1.5% Solution

Prescription medicationSolution
Ingredient · strength
Glucose Hydrate›41.25gCalcium Chloride Hydrate›0.507gMagnesium Chloride›0.14gSodium Chloride›8.43gSodium Bicarbonate›3.29gSodium Lactate 50%›5.26g
Manufacturer / importer
Boryeong (Co., Ltd.)
Appearance
This medicine is a pale yellow transparent peritoneal dialysis solution in a colorless and transparent plastic bag with two chambers.
Packaging
2L/bag (A solution:B solution = 725:1275)
Approval status
Active

MFDS item code 200401270 · Notified 2004.07.12

Summary

Main use
Peritoneal dialysis for renal failure, detoxification of drug poisoning, relief of discomfort caused by low-pH dialysate
Who uses it
Adults
Adult dosage
1. The attending physician should adjust the treatment regimen, number of exchanges, exchange volume, dialysis time, and treatment duration according to the patient's condition. 2. Use as a solution for dialysis treatment by intraperitoneal administration. 3. The dose varies according to body size, and the frequency of solution exchanges should be adjusted appropriately based on biochemical parameters and fluid balance. In general, adults receive 1.5~2.5L intraperitoneally per exchange, which is retained for 4~8 hours and then drained; this process is performed 3~5 times daily. 4. When a machine is used intermittently or continuously for peritoneal dialysis, it is preferable to use a bag with a volume greater than the machine's exchange volume. 5. The glucose concentration should be selected according to the patient's ultrafiltration needs and kept as low as possible.

Ingredients

Manufacturer
Boryeong (Co., Ltd.)

Efficacy & effects

Peritoneal dialysis for renal failure, detoxification of drug poisoning, relief of discomfort caused by low-pH dialysate

  • Acute and chronic renal failure
  • drug overdose
  • discomfort due to low pH
View approved original text

This medication is used as a peritoneal dialysis solution for patients with acute and chronic renal failure. It can also help detoxify drug overdoses that do not respond to other treatments through the dialysis material. It is prescribed to reduce discomfort caused by low pH when using dialysis solution composed solely of lactate. Therefore, this medicine aids in the dialysis treatment of patients with renal failure and in detoxifying drug overdoses.

Dosage and Administration

Adult dosage

1. The attending physician should adjust the treatment regimen, number of exchanges, exchange volume, dialysis time, and treatment duration according to the patient's condition. 2. Use as a solution for dialysis treatment by intraperitoneal administration. 3. The dose varies according to body size, and the frequency of solution exchanges should be adjusted appropriately based on biochemical parameters and fluid balance. In general, adults receive 1.5~2.5L intraperitoneally per exchange, which is retained for 4~8 hours and then drained; this process is performed 3~5 times daily. 4. When a machine is used intermittently or continuously for peritoneal dialysis, it is preferable to use a bag with a volume greater than the machine's exchange volume. 5. The glucose concentration should be selected according to the patient's ultrafiltration needs and kept as low as possible.

Precautions

This solution is for peritoneal dialysis; during treatment, infections such as peritonitis may occur, so it should always be used in a clean and sterile environment. If peritoneal dialysis is suddenly discontinued, waste products may accumulate in the body, and excessive fluid buildup can pose a life-threatening risk, so treatment should always be stopped according to a doctor's instructions. This medicine should not be used in patients with specific conditions, such as those with diaphragmatic defects, severe abdominal inflammation or surgical history, bleeding tendencies, or suspected lactate metabolism disorders. Moreover, patients on digitoxin therapy, those suspected of having carbohydrate metabolism disorders, patients using artificial anus, or those on diuretics should regularly check electrolyte levels and blood sugar when using this medicine. When using this medication, various adverse reactions such as abdominal pain, bleeding, symptoms of peritonitis, electrolyte imbalance, metabolic abnormalities, and respiratory distress may occur, so if symptoms arise, immediate consultation with medical personnel is required. The dialysis solution must be used while sealed in the provided container, and should not be used if the packaging is damaged or if the solution is cloudy or contains foreign substances. Pregnant or breastfeeding women should only use this medication when the benefits of treatment outweigh the risks, as its safety has not been established. In children, the dosage of the dialysis solution should be adjusted according to age and weight, and in the elderly, the possibility of hernia should be considered prior to peritoneal dialysis. Overdose may result in dehydration, electrolyte abnormalities, hyperglycemia, etc., so dialysis exchanges should be performed at appropriate frequencies and dosages, and immediate medical attention should be sought in case of unusual symptoms. Peritoneal dialysis treatment must always be initiated under medical supervision, and even when self-administering, it should be done only after adequate training, with regular monitoring of weight and blood tests to maintain thorough management of the body's condition.

Side effects

Abdominal pain, bleeding, peritonitis, abdominal colic, cloudy discharge, fever, inflammation around the abdominal catheter, erythema, secretion, catheter rupture, subcutaneous inflammation when drainage is difficult, nausea, diarrhea, constipation, hemorrhoids, vomiting, loss of appetite, abdominal distension, intestinal obstruction, hypokalemia, hyponatremia, hypocalcemia, hypophosphatemia, hyperlactatemia, hypomagnesemia, hypercholesterolemia, hypertriglyceridemia, metabolic acidosis, hypoproteinemia, hyperglycemia, dyspnea due to diaphragm elevation, pulmonary edema, pleural effusion, secondary hyperparathyroidism, edema, amino acid loss, water-soluble vitamin loss, shoulder pain, muscle cramps, hernia, hydrocele, obesity, frailty, syncope, fatigue, headache, dizziness, tachycardia, hypertension, hypotension, sclerosing encapsulating peritonitis, sepsis

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a sealed container to prevent air and moisture exposure. Furthermore, it is important to store it in a cool place below 25 degrees Celsius and not to freeze it to maintain its effectiveness.

Appearance and packaging

Appearance

This medicine is a pale yellow transparent peritoneal dialysis solution in a colorless and transparent plastic bag with two chambers.

Package unit

2L/bag (A solution:B solution = 725:1275)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.